ACT-HBV® : Advancing the Clinical Treatment of Hepatitis B Virus
Home CME Center Clinical Trials About ACT-HBV® Treatment Algorithms and Guidelines Ask the Experts
About ACT-HBV
We welcome your comments. Please feel free to complete the form below with any questions, suggestions, or technical difficulties that you may have regarding ACT-HBV.com.
(* indicates required fields)
 
* Name:
* E-mail:
Date: 7/4/2008
* Subject:
* Message:
  Submit
 
 
Online ResourcesContact Us Refer a Colleague Send Me Updates Legal Disclaimer
  
   
 
MDGUniversity of Wisconsin Medical School
The ACT-HBV Initiative in the United States is supported by independent educational grants from Bristol-Myers Squibb Company and Gilead Sciences. The ACT-HBV Initiative in the Asia-Pacific Region is supported by independent educational grants from Bristol-Myers Squibb Company and Novartis Pharma AG.